4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β−selection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Signals from the pre-T cell receptor and Notch coordinately instruct β-selection of CD4 CD8 double negative (DN) thymocytes to generate αβ T cells in the thymus. However, how these signals ensure a high-fidelity proteome and safeguard the clonal diversification of the pre-selection TCR repertoire given the considerable translational activity imposed by β-selection is largely unknown. Here, we identify the endoplasmic reticulum (ER)-associated degradation (ERAD) machinery as a critical proteostasis checkpoint during β-selection. Expression of the SEL1L-HRD1 complex, the most conserved branch of ERAD, is directly regulated by the transcriptional activity of the Notch intracellular domain. Deletion of Sel1l impaired DN3 to DN4 thymocyte transition and severely impaired mouse αβ T cell development. Mechanistically, Sel1l deficiency induced unresolved ER stress that triggered thymocyte apoptosis through the PERK pathway. Accordingly, genetically inactivating PERK rescued T cell development from Sel1l-deficient thymocytes. In contrast, IRE1α/XBP1 pathway was induced as a compensatory adaptation to alleviate Sel1l-deficiency-induced ER stress. Dual loss of Sel1l and Xbp1 markedly exacerbated the thymic defect. Our study reveals a critical developmental signal controlled proteostasis mechanism that enforces T cell development to ensure a healthy adaptive immunity.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: not found

          The unfolded protein response: from stress pathway to homeostatic regulation.

          The vast majority of proteins that a cell secretes or displays on its surface first enter the endoplasmic reticulum (ER), where they fold and assemble. Only properly assembled proteins advance from the ER to the cell surface. To ascertain fidelity in protein folding, cells regulate the protein-folding capacity in the ER according to need. The ER responds to the burden of unfolded proteins in its lumen (ER stress) by activating intracellular signal transduction pathways, collectively termed the unfolded protein response (UPR). Together, at least three mechanistically distinct branches of the UPR regulate the expression of numerous genes that maintain homeostasis in the ER or induce apoptosis if ER stress remains unmitigated. Recent advances shed light on mechanistic complexities and on the role of the UPR in numerous diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis.

            Dendritic cells (DCs) are required to initiate and sustain T cell-dependent anti-cancer immunity. However, tumors often evade immune control by crippling normal DC function. The endoplasmic reticulum (ER) stress response factor XBP1 promotes intrinsic tumor growth directly, but whether it also regulates the host anti-tumor immune response is not known. Here we show that constitutive activation of XBP1 in tumor-associated DCs (tDCs) drives ovarian cancer (OvCa) progression by blunting anti-tumor immunity. XBP1 activation, fueled by lipid peroxidation byproducts, induced a triglyceride biosynthetic program in tDCs leading to abnormal lipid accumulation and subsequent inhibition of tDC capacity to support anti-tumor T cells. Accordingly, DC-specific XBP1 deletion or selective nanoparticle-mediated XBP1 silencing in tDCs restored their immunostimulatory activity in situ and extended survival by evoking protective type 1 anti-tumor responses. Targeting the ER stress response should concomitantly inhibit tumor growth and enhance anti-cancer immunity, thus offering a unique approach to cancer immunotherapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Plasma cell differentiation requires the transcription factor XBP-1.

              Considerable progress has been made in identifying the transcription factors involved in the early specification of the B-lymphocyte lineage. However, little is known about factors that control the transition of mature activated B cells to antibody-secreting plasma cells. Here we report that the transcription factor XBP-1 is required for the generation of plasma cells. XBP-1 transcripts were rapidly upregulated in vitro by stimuli that induce plasma-cell differentiation, and were found at high levels in plasma cells from rheumatoid synovium. When introduced into B-lineage cells, XBP-1 initiated plasma-cell differentiation. Mouse lymphoid chimaeras deficient in XBP-1 possessed normal numbers of activated B lymphocytes that proliferated, secreted cytokines and formed normal germinal centres. However, they secreted very little immunoglobulin of any isotype and failed to control infection with the B-cell-dependent polyoma virus, because plasma cells were markedly absent. XBP-1 is the only transcription factor known to be selectively and specifically required for the terminal differentiation of B lymphocytes to plasma cells.
                Bookmark

                Author and article information

                Contributors
                Role: Reviewing Editor
                Role: Senior Editor
                Journal
                eLife
                Elife
                eLife
                eLife
                eLife Sciences Publications, Ltd
                2050-084X
                09 July 2021
                2021
                : 10
                : e69975
                Affiliations
                [1 ]Department of Molecular and Cellular Biology, Baylor College of Medicine HoustonUnited States
                [2 ]Lester and Sue Smith Breast Center and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine HoustonUnited States
                [3 ]Department of Pathology, School of Medicine, Case Western Reserve University ClevelandUnited States
                [4 ]Center for Molecular Medicine and Genetics, Wayne State University DetroitUnited States
                [5 ]Department of Chemistry and Physics, La Trobe University MelbourneAustralia
                [6 ]Department of Molecular and Integrative Physiology, University of Michigan Medical School Ann ArborUnited States
                University of Toronto, Sunnybrook Research Institute Canada
                Indian Institute of Science Education and Research (IISER) India
                University of Toronto, Sunnybrook Research Institute Canada
                University of Toronto, Sunnybrook Research Institute Canada
                Fox Chaser Cancer Center United States
                Author notes
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-2408-5809
                https://orcid.org/0000-0002-8574-4062
                https://orcid.org/0000-0001-6416-0466
                https://orcid.org/0000-0002-7995-6202
                Article
                69975
                10.7554/eLife.69975
                8315795
                34240701
                a7053182-d41e-43a4-909e-c35c1bb6944b
                © 2021, Liu et al

                This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

                History
                : 03 May 2021
                : 05 July 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000050, National Heart, Lung, and Blood Institute;
                Award ID: R01HL146642
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
                Award ID: R01 AI1143992
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: R37CA228304
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: K22CA218467
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: P50CA186784
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000057, National Institute of General Medical Sciences;
                Award ID: R35GM130292
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100014042, DOD Peer Reviewed Cancer Research Program;
                Award ID: W81XWH1910524
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100014042, DOD Peer Reviewed Cancer Research Program;
                Award ID: W81XWH1910306
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000090, Congressionally Directed Medical Research Programs;
                Award ID: W81XWH1910035
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004917, Cancer Prevention and Research Institute of Texas;
                Award ID: RP160283
                Award Recipient :
                The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
                Categories
                Research Article
                Developmental Biology
                Immunology and Inflammation
                Custom metadata
                Endoplasmic reticulum-associated degradation (ERAD) is a critical protein quality control checkpoint for thymocyte β-slection.

                Life sciences
                thymocytes,proteostasis,beta-selection,er-associated degradation,er stress,mouse
                Life sciences
                thymocytes, proteostasis, beta-selection, er-associated degradation, er stress, mouse

                Comments

                Comment on this article